Healthcare Regulatory Check-Up Newsletter | October 2024 Recap

McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. With more than 1,100 lawyers across several office locations worldwide, our team works seamlessly across practices, industries and geographies to deliver highly effective solutions that propel success.

Explore Firm Details

This issue of McDermott's Healthcare Regulatory Check-Up highlights regulatory activity for October 2024. We discuss several enforcement actions pertaining to healthcare fraud, including alleged...

United States Food, Drugs, Healthcare, Life Sciences

Tony Maida,Emily Cook,Amanda Enyeart

+4 Authors

Your Author LinkedIn Connections

Article Insights

McDermott Will & Emery are most popular:

with readers working within the Insurance industries

This issue of McDermott's Healthcare Regulatory Check-Up highlights regulatory activity for October 2024. We discuss several enforcement actions pertaining to healthcare fraud, including alleged violations under the False Claims Act (FCA) and the federal Anti-Kickback Statute (AKS). We also review other regulatory updates in the healthcare field, including notable updates from the Centers for Medicare & Medicaid Services (CMS).

READ FULL REPORT.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Authors